145 related articles for article (PubMed ID: 27887573)
1. In-vitro function of upstream visfatin polymorphisms that are associated with adverse cardiometabolic parameters in obese children.
Ooi DS; Ong SG; Heng CK; Loke KY; Lee YS
BMC Genomics; 2016 Nov; 17(1):974. PubMed ID: 27887573
[TBL] [Abstract][Full Text] [Related]
2. Visfatin and its genetic variants are associated with obesity-related morbidities and cardiometabolic risk in severely obese children.
Ooi SQ; Chan RM; Poh LK; Loke KY; Heng CK; Chan YH; Gan SU; Lee KO; Lee YS
Pediatr Obes; 2014 Apr; 9(2):81-91. PubMed ID: 23447513
[TBL] [Abstract][Full Text] [Related]
3. Genetic variant in visfatin gene promoter contributes to reduced risk of hepatocellular carcinoma in a Chinese population.
Wu Z; Sun Y; Huang Y; Zhu S; Feng Y; Ye H; Liu C; Tang S
Oncotarget; 2016 Nov; 7(47):77968-77977. PubMed ID: 27792999
[TBL] [Abstract][Full Text] [Related]
4. Mechanistic insights into the link between visfatin gene C-1535T polymorphism and coronary artery disease: an in vitro study.
Wang YS; Gao W; Li HF; Wang ZM; Zhu J; Zhao H; Yan JJ; Jia EZ; Yang ZJ; Wang LS
Mol Cell Biochem; 2012 Apr; 363(1-2):315-22. PubMed ID: 22147201
[TBL] [Abstract][Full Text] [Related]
5. The effects of NAMPT haplotypes and metabolic risk factors on circulating visfatin/NAMPT levels in childhood obesity.
Belo VA; Luizon MR; Lacchini R; Miranda JA; Lanna CM; Souza-Costa DC; Tanus-Santos JE
Int J Obes (Lond); 2015 Jan; 39(1):130-5. PubMed ID: 24100423
[TBL] [Abstract][Full Text] [Related]
6. The -1535 promoter variant of the visfatin gene is associated with serum triglyceride and HDL-cholesterol levels in Japanese subjects.
Tokunaga A; Miura A; Okauchi Y; Segawa K; Fukuhara A; Okita K; Takahashi M; Funahashi T; Miyagawa J; Shimomura I; Yamagata K
Endocr J; 2008 Mar; 55(1):205-12. PubMed ID: 18270432
[TBL] [Abstract][Full Text] [Related]
7. Association of genetic variability in selected regions in visfatin (NAMPT) gene with anthropometric parameters and dietary composition in obese and non-obese Central-European population.
Stastny J; Bienertova-Vasku J; Tomandl J; Tomandlova M; Zlamal F; Forejt M; Splichal Z; Vasku A
Diabetes Metab Syndr; 2013; 7(3):166-71. PubMed ID: 23953183
[TBL] [Abstract][Full Text] [Related]
8. The -928 G/C and -362 G/C single-nucleotide polymorphisms in the promoter of MCP-1: Increased transcriptional activity and novel binding sites.
Nyquist P; Zhang J; De Graba TJ
Cerebrovasc Dis; 2010 Feb; 29(3):242-7. PubMed ID: 20029197
[TBL] [Abstract][Full Text] [Related]
9. Obesity and Cardiovascular Risk: Variations in Visfatin Gene Can Modify the Obesity Associated Cardiovascular Risk. Results from the Segovia Population Based-Study. Spain.
Martínez Larrad MT; Corbatón Anchuelo A; Fernández Pérez C; Pérez Barba M; Lazcano Redondo Y; Serrano Ríos M;
PLoS One; 2016; 11(5):e0153976. PubMed ID: 27166797
[TBL] [Abstract][Full Text] [Related]
10. A rare variant in the visfatin gene (NAMPT/PBEF1) is associated with protection from obesity.
Blakemore AI; Meyre D; Delplanque J; Vatin V; Lecoeur C; Marre M; Tichet J; Balkau B; Froguel P; Walley AJ
Obesity (Silver Spring); 2009 Aug; 17(8):1549-53. PubMed ID: 19300429
[TBL] [Abstract][Full Text] [Related]
11. Curcumin down-regulates visfatin expression and inhibits breast cancer cell invasion.
Kim SR; Park HJ; Bae YH; Ahn SC; Wee HJ; Yun I; Jang HO; Bae MK; Bae SK
Endocrinology; 2012 Feb; 153(2):554-63. PubMed ID: 22186408
[TBL] [Abstract][Full Text] [Related]
12. Genetic variant in visfatin gene promoter is associated with decreased risk of coronary artery disease in a Chinese population.
Yan JJ; Tang NP; Tang JJ; Jia EZ; Wang MW; Wang QM; Zhu J; Yang ZJ; Wang LS; Huang J
Clin Chim Acta; 2010 Jan; 411(1-2):26-30. PubMed ID: 19804767
[TBL] [Abstract][Full Text] [Related]
13. Common polymorphisms in the promoter of the visfatin gene (PBEF1) influence plasma insulin levels in a French-Canadian population.
Bailey SD; Loredo-Osti JC; Lepage P; Faith J; Fontaine J; Desbiens KM; Hudson TJ; Bouchard C; Gaudet D; Pérusse L; Vohl MC; Engert JC
Diabetes; 2006 Oct; 55(10):2896-902. PubMed ID: 17003359
[TBL] [Abstract][Full Text] [Related]
14. Functional characterization of variants in MC4R gene promoter region found in obese children.
Tan KM; Ooi SQ; Ong SG; Kwan CS; Chan RM; Seng Poh LK; Mendoza J; Heng CK; Loke KY; Lee YS
J Clin Endocrinol Metab; 2014 May; 99(5):E931-5. PubMed ID: 24512492
[TBL] [Abstract][Full Text] [Related]
15. Plasma visfatin, associated with a genetic polymorphism -1535C>T, is correlated with C-reactive protein in Chinese Han patients with traumatic brain injury.
Weng JF; Chen J; Hong WC; Luo LF; Yu W; Luo SD
Peptides; 2013 Feb; 40():8-12. PubMed ID: 23270673
[TBL] [Abstract][Full Text] [Related]
16. Increased transcriptional activity of the CYP3A4*1B promoter variant.
Amirimani B; Ning B; Deitz AC; Weber BL; Kadlubar FF; Rebbeck TR
Environ Mol Mutagen; 2003; 42(4):299-305. PubMed ID: 14673875
[TBL] [Abstract][Full Text] [Related]
17. Effects of NAMPT polymorphisms and haplotypes on circulating visfatin/NAMPT levels in hypertensive disorders of pregnancy.
Luizon MR; Belo VA; Palei AC; Amaral LM; Lacchini R; Sandrim VC; Duarte G; Cavalli RC; Tanus-Santos JE
Hypertens Res; 2015 May; 38(5):361-6. PubMed ID: 25716650
[TBL] [Abstract][Full Text] [Related]
18. Regulatory single nucleotide polymorphisms (rSNPs) at the promoters 1A and 1B of the human APC gene.
Matveeva MY; Kashina EV; Reshetnikov VV; Bryzgalov LO; Antontseva EV; Bondar NP; Merkulova TI
BMC Genet; 2016 Dec; 17(Suppl 3):154. PubMed ID: 28105931
[TBL] [Abstract][Full Text] [Related]
19. Functional dissection of an IFN-alpha/beta receptor 1 promoter variant that confers higher risk to chronic hepatitis B virus infection.
Zhou J; Huang JD; Poon VK; Chen DQ; Chan CC; Ng F; Guan XY; Watt RM; Lu L; Yuen KY; Zheng BJ
J Hepatol; 2009 Aug; 51(2):322-32. PubMed ID: 19501422
[TBL] [Abstract][Full Text] [Related]
20. Genetic variation in the visfatin gene (PBEF1) and its relation to glucose metabolism and fat-depot-specific messenger ribonucleic acid expression in humans.
Böttcher Y; Teupser D; Enigk B; Berndt J; Klöting N; Schön MR; Thiery J; Blüher M; Stumvoll M; Kovacs P
J Clin Endocrinol Metab; 2006 Jul; 91(7):2725-31. PubMed ID: 16636125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
